New treatment for common nail infection

October 19, 2016, University of Southampton
New treatment for common nail infection
Cold atmospheric gas plasma used to treat common nail infections. Credit: University of Southampton

Researchers at the University of Southampton are trialling a new treatment for fungal nail infections, which may revolutionise the treatment of this common problem.

Many adults in the UK will develop a fungal nail infection (onychomycosis) at some point in their lives, which causes the nail to become discoloured, thickened and distorted; it usually affects the toenails.

It can be painful and current treatments are often ineffective or slow to work increasing the risk of the infection worsening and needing antibiotics. New treatments are needed, which have limited side effects and are better at clearing nail infection quickly.

Researchers from the University of Southampton's Network for Antimicrobial Resistance and Infection Prevention (NAMRIP) together with colleagues from Solent NHS Trust are trialling a new treatment developed by BOC (A Linde Group company), which uses cold atmospheric gas plasma.

Cold Atmospheric Plasma is an ionized mix of gases that has been used in a range of medical applications from cleaning instruments to teeth whitening. Most gas plasmas have , and it is this property being tested in this study.

The plasma comes from a small device that can target the infection more precisely.

"Fungal nail infections might be seen as a purely cosmetic problem, but in people with diabetes, it can lead to very serious infections which are difficult to treat," said Dr David Voegeli, who is leading the study.

"We believe this new way of treating patients will be more effective in getting to the infection quickly, possibly reducing the need for antibiotics in the future."

Professor Tim Leighton, chair of NAMRIP, said "We are facing huge challenges in and we desperately need to find new ways of treating conditions before they need antibiotics. This is an exciting study which has great potential in treating a common condition early before antibiotic interventions are needed."

The study aims to recruit 80 people with in both large toenails. Following a screening test to determine eligibility, the treatment will take place within Solent's Podiatry service at Adelaide Health Centre, Southampton.

Explore further: High heels are leading cause of ingrown toenails

More information: Anyone interested in taking part in the study can find out more by calling the research team on 07919 063451 or by email at

Related Stories

High heels are leading cause of ingrown toenails

February 28, 2012
High heels can cause a number of foot problems, yet most women aren’t willing to give their shoes the boot, according to podiatrists at Loyola University Health System (LUHS). Ingrown toenails are among the most common ...

Experimental antibiotic treats deadly MRSA infection

June 13, 2016
A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective ...

Novel algorithm predicts drug combinations to treat drug resistant fungal infections

July 14, 2016
Scientists have created an algorithm that can identify drug combinations to treat fungal infections that have become resistant to current drug treatments. This new study, published in PLOS Computational Biology, represents ...

Resistance to antibiotics and to immune system are interconnected in bacteria

June 30, 2016
Antibiotics and the immune system are the two forces that cope with bacterial infections. Now, two studies from Isabel Gordo's laboratory, at Instituto Gulbenkian de Ciência (IGC, Portugal), show for the first time that ...

Proper foot hygiene is key for 'Happy Feet' this summer

April 29, 2016
As warmer temperatures approach, in the midst of getting your beach body ready, don't forget to take care of your feet, said Dr. Ronald Lepow, a podiatrist and assistant professor of orthopedic surgery at Baylor College of ...

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.